Advertisement
For certain men

Outlook Good for Localized Prostate CA, Despite Tx Chosen

0
Survival rates high for active surveillance, radiation, or prostatectomy
More than one-quarter of Americans over 50 don't exercise

CDC: Many U.S. Adults Over 50 Do Not Exercise Regularly

0
Inactivity boosts risk for falls, broken bones, serious disease, and early death, CDC warns
Physician-assessed drug importance is not associated with patient-reported drug adherence

Importance of Drug As Assessed by Doctor Not Tied to Adherence

0
About 20 percent of drugs considered important by physicians were not taken correctly by patients
A new set of recommendations has been developed for conduct and reporting of cost-effectiveness analyses

Recommendations Developed for Cost-Effectiveness Analyses

0
Concept of reference case, set of standard practices that all analyses should follow is recommended
A multifaceted value-driven outcomes tool that identifies variability in costs and outcomes can reduce health care costs

Value-Driven Outcomes Tool Can Cut Health Care Costs

0
Highest variability in costs identified for post-op infection and sepsis, lowest for organ transplant
For patients with early-stage colorectal cancer

Metabolic Syndrome and Obesity Up Risk of Mortality in CRC

0
Obese patients with metabolic syndrome have increased risk of all-cause, CRC-related death
New anticancer drugs

New Anticancer Drugs Up Costs and Life Expectancy Considerably

0
Lifetime costs up $72,000, life expectancy up 13 months with new drug use in breast cancer
For patients with non-small-cell lung cancer

Similar NSCLC Survival for Surgical, Endosonographic Staging

0
Five-year survival not significantly different after mediastinoscopy or endosonographic staging
Magnifying endoscopy with image enhanced system may provide better diagnostic performance than conventional white light imaging for early gastric cancer

Magnifying Endoscopy With Enhanced Imaging IDs Gastric CA

0
ME-IEE may provide better diagnostic performance than conventional white light imaging
For patients with stage IIIC to IV ovarian cancer

Neoadjuvant Chemotherapy Use Up in Ovarian Cancer Treatment

0
NACT use up from 2003 to 2012; linked to shorter overall survival in stage IIIC but not stage IV disease